My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

NovoCure Limited - Ordinary Shares (NQ:NVCR)

14.35 -0.52 (-3.50%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NovoCure Limited - Ordinary Shares

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

Cramer Likes Ford, But Suggests Waiting For Dips To Buy These Stocks ↗

October 11, 2021

On Friday's "Mad Money Lightning ...

Via Benzinga

Novocure and Zai Lab Announce Last Patient Enrolled in Phase 2 Pilot Trial of Tumor Treating Fields Plus Chemotherapy as First-Line Treatment in Gastric Cancer in China

October 04, 2021

From Novocure

Via Business Wire

Novocure to Report Third Quarter 2021 Financial Results

October 04, 2021

From Novocure

Via Business Wire

Novocure To Test Its Tumor Treating Fields With Roche's Tecentriq In Pancreatic Cancer ↗

September 14, 2021

Novocure Ltd (NASDAQ: NVCR) has entered into a clinical trial collaboration agreement with Roche Holdings AG (OTC: RHHBY) to develop Tumor Treating...

Via Benzinga

NovoCure: Q2 Earnings Insights ↗

July 29, 2021

Shares of NovoCure (NASDAQ:NVCR) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share were down 800.00% over the past year to ($0...

Via Benzinga

Earnings Scheduled For July 29, 2021 ↗

July 29, 2021

Companies Reporting Before The Bell • Smith & Nephew (NYSE:SNN) is projected to report earnings for its second quarter. • Cohen & Co (AMEX:COHN) is...

Via Benzinga

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal ↗

October 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (...

Via Benzinga

The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout ↗

September 14, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE...

Via Benzinga

Novocure Announces Clinical Trial Collaboration with Roche to Evaluate Tumor Treating Fields as Part of a Novel Combination for the First-line Treatment of Metastatic Pancreatic Cancer

September 14, 2021

From Novocure

Via Business Wire

Pressure Day ↗

September 13, 2021

Today a recovery came to markets with a particular impact on uranium shares.

Via Talk Markets

A Weak Week ↗

September 10, 2021

Chinese car-maker Nio appears to have been able to weather the Beijing crackdown on foreign listed firms better than later entrants.

Via Talk Markets

Delta Variant Fears Continue ↗

September 09, 2021

The jobless level fell to 310,000 whereas the consensus forecast was for 335,000, so risks of inflation are higher.

Via Talk Markets

This Promising Healthcare Stock Is Down 50% From Its Highs; Should You Buy the Dip? ↗

September 09, 2021

Novocure has been fantastic for investors, up over 1,600% in the past five years. But in the past six months, shareholders have been on a roller coaster.

Via The Motley Fool

FDA Grants Breakthrough Device Designation to the NovoTTF-200T™ System for Advanced Liver Cancer

September 09, 2021

From Novocure

Via Business Wire

Novocure to Participate in the 2021 Wells Fargo Virtual Healthcare Conference

September 02, 2021

From Novocure

Via Business Wire

Novocure Appoints Bill Burke as Chief Human Resources Officer

September 01, 2021

From Novocure

Via Business Wire

Friday the Thirteenth ↗

August 13, 2021

The stock week in points eastward was mixed. The USA markets face a bear correction.

Via Talk Markets

What's Next for Novocure? ↗

August 13, 2021

The company has several key data readouts on the way.

Via The Motley Fool

Delta Outbreak ↗

August 04, 2021

The US market was droopy because of poor private sector jobless numbers.

Via Talk Markets

Cramer Advises Viewers On Palantir, SoFi And More ↗

August 04, 2021

On CNBC's "Mad Money Lightning Round," Jim Cramer said he doesn't understand why is MKS Instruments, Inc. (NASDAQ: MKSI) trading so cheap. He would be a buyer....

Via Benzinga

Know When To Hold 'Em, Know When To Fold 'Em ... ↗

August 02, 2021

A long Monday list identifying some sensible and some impenetrable moves behind today's market in our stocks.

Via Talk Markets

Here's Why Novocure Dipped 19% This Week ↗

July 30, 2021

Uptake of the company's revolutionary disease-controlling device isn't progressing as quickly as expected.

Via The Motley Fool

News Overload ↗

July 29, 2021

Today US markets managed a rally despite misses in both the growth and employment data.

Via Talk Markets

70 Biggest Movers From Yesterday ↗

July 30, 2021

Gainers Xenetic Biosciences, Inc. (NASDAQ: XBIO) shares surged 65.1% to settle at $5.30 on Thursday. Xenetic Biosciences recently reported closing of $12.5 million private...

Via Benzinga

Why Novocure Tanked on Thursday ↗

July 29, 2021

Investors are seeing red in the company's latest earnings report.

Via The Motley Fool

NovoCure (NVCR) Q2 2021 Earnings Call Transcript ↗

July 29, 2021

NVCR earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs ↗

July 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Novocure Stock Dips As Q2 Earnings Trail Estimates; Higher Costs Hit Bottom Line ↗

July 29, 2021

Novocure Ltd (NASDAQ: NVCR) posted a net loss of $14.6 million in Q2, compared to a net income of $1.7 million a year ago. EPS came in at $(0.14), missing the consensus...

Via Benzinga

Novocure Reports Second Quarter 2021 Financial Results and Provides Company Update

July 29, 2021

From Novocure

Via Business Wire

Full News Day ↗

July 28, 2021

The US greatly increased its exports of liquified natural gas in the first half-year, to 9.6 billion cubic feet per day, a rise of 42% from a year earlier.

Via Talk Markets

Topics Energy

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.